首页|1例复合杂合突变导致遗传性凝血因子Ⅺ缺陷症的分子致病机制

1例复合杂合突变导致遗传性凝血因子Ⅺ缺陷症的分子致病机制

Molecular mechanism analysis of a family with hereditary coagulation F Ⅺ deficiency caused by compound heterozygous mutations

扫码查看
1例34岁女性患者因"乳房结节"拟行手术切除,术前检查发现活化部分凝血活酶时间(APTT)66.2 s、凝血因子Ⅺ活性(FⅪ:C)2%、FⅪ抗原(FⅪ:Ag)40.3%,患者及家系成员均无异常出血表现.诊断为遗传性凝血因子Ⅺ缺陷症.基因检测发现其F11基因第10外显子c.1107C>A(p.Tyr351stop)杂合无义突变、第13外显子c.1562A>G(p.Tyr503Cys)杂合错义突变,其父亲和儿子为p.Tyr351stop突变的杂合携带者,而母亲和女儿为p.Tyr503Cys突变的杂合携带者.体外表达结果显示,p.Tyr351stop突变导致F1 1基因转录水平显著降低,而p.Tyr503Cys突变对F11基因转录水平以及蛋白表达水平无影响,但该突变导致细胞培养上清液中FⅪ:C水平显著降低.
A 34 year old female patient was scheduled to undergo surgical resection due to a"breast nodule".Preoperative examination revealed an activated partial thromboplastin time(APTT)of 66.2 seconds,coagulation factor Ⅺ activity(FⅪ:C)of 2%,and FⅪ antigen(FⅪ:Ag)of 40.3%.The patient and family members showed no abnormal bleeding symptoms.Diagnosed as hereditary coagulation factor Ⅺ deficiency.Genetic testing revealed that the F11 gene had a heterozygous nonsense mutation in exon 10,c.1107C>A(p.Tyr351stop),and a heterozygous missense mutation in exon 13,c.1562A>G(p.Tyr503Cys).The father and son were p Heterozygous carriers of Tyr351stop mutation,while the mother and daughter are p Heterozygous carriers of Tyr503Cys mutations.The in vitro expression results showed that p The Tyr351stop mutation resulted in a significant decrease in the transcription level of F11 gene,while p The Tyr503Cys mutation has no effect on the transcription level and protein expression level of F1 1 gene,but it leads to a significant decrease in the level of FⅪ:C in the cell culture supernatant.

陈元、秦朗译、林双女、杨丽红、张柯、叶龙颖、金艳慧、王明山

展开 >

温州医科大学附属第一医院医学检验中心,浙江省检验诊断及转化研究重点实验室,温州 325015

温州市公益科技基金浙江省检验诊断及转化研究重点实验室项目

Y20201102022E10022

2024

中华血液学杂志
中华医学会

中华血液学杂志

CSTPCD北大核心
影响因子:1.17
ISSN:0253-2727
年,卷(期):2024.45(3)
  • 18